Dr. Mustapha Bittaye
Dr. Mustapha Bittaye started his scientific career at the Medical Research Council Unit, The Gambia where he had initially worked as a research assistant and then as scientific officer on several disease programmes including Malaria. He completed a BSc (Hons) degree in Biomedical science from the University of Westminster and then moved to the University of Aberdeen, where he completed a PhD in microbial proteomics. As a postdoctoral researcher at the Jenner Institute (University of Oxford) involved in the clinical development of vaccines against emerging viral pathogens such as Middle East Respiratory Syndrome coronavirus, Lassa and Nipah viruses, Bittaye is also one of the core scientists involved in the development of the Oxford/AstraZeneca vaccine. Apart from developing and validating the antibody assay used as the primary readout for assessing the antibody response against the ChAdOx1 nCoV-19 vaccine, he also co-leads a team involved in measuring the magnitude and durability of the antibodies induced by the vaccine in both UK and overseas trial volunteers.